HomeCompareIDRA vs BTI

IDRA vs BTI: Dividend Comparison 2026

IDRA yields 470.59% · BTI yields 5.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IDRA wins by $38545.08M in total portfolio value
10 years
IDRA
IDRA
● Live price
470.59%
Share price
$0.43
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$38545.12M
Annual income
$27,182,357,871.92
Full IDRA calculator →
BTI
BTI
● Live price
5.40%
Share price
$58.26
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.8K
Annual income
$2,802.29
Full BTI calculator →

Portfolio growth — IDRA vs BTI

📍 IDRA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIDRABTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IDRA + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IDRA pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IDRA
Annual income on $10K today (after 15% tax)
$40,000.00/yr
After 10yr DRIP, annual income (after tax)
$23,105,004,191.13/yr
BTI
Annual income on $10K today (after 15% tax)
$459.05/yr
After 10yr DRIP, annual income (after tax)
$2,381.95/yr
At 15% tax rate, IDRA beats the other by $23,105,001,809.19/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IDRA + BTI for your $10,000?

IDRA: 50%BTI: 50%
100% BTI50/50100% IDRA
Portfolio after 10yr
$19272.58M
Annual income
$13,591,180,337.10/yr
Blended yield
70.52%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

IDRA
Analyst Ratings
5
Buy
4
Hold
Consensus: Buy
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.3% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IDRA buys
0
BTI buys
0
No recent congressional trades found for IDRA or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIDRABTI
Forward yield470.59%5.40%
Annual dividend / share$2.00$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3%
Portfolio after 10y$38545.12M$37.8K
Annual income after 10y$27,182,357,871.92$2,802.29
Total dividends collected$37542.88M$14.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: IDRA vs BTI ($10,000, DRIP)

YearIDRA PortfolioIDRA Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$57,759$47,058.82$11,301$601.08+$46.5KIDRA
2$315,826$254,024.51$12,799$706.58+$303.0KIDRA
3$1,636,076$1,298,141.44$14,527$832.38+$1.62MIDRA
4$8,035,425$6,284,824.27$16,527$982.75+$8.02MIDRA
5$37,445,846$28,847,941.19$18,846$1,162.95+$37.43MIDRA
6$165,706,448$125,639,392.36$21,545$1,379.49+$165.68MIDRA
7$696,916,266$519,610,366.98$24,694$1,640.41+$696.89MIDRA
8$2,788,074,169$2,042,373,764.24$28,378$1,955.69+$2788.05MIDRA
9$10,619,401,952$7,636,162,591.12$32,702$2,337.79+$10619.37MIDRA
10$38,545,117,961$27,182,357,871.92$37,794$2,802.29+$38545.08MIDRA

IDRA vs BTI: Complete Analysis 2026

IDRAStock

Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors, squamous cell carcinoma of the head and neck, and colorectal cancer. The company has a collaboration agreement with Bristol-Meyers Squibb. Idera Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania.

Full IDRA Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this IDRA vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IDRA vs SCHDIDRA vs JEPIIDRA vs OIDRA vs KOIDRA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.